Related by context. Frequent words. (Click for all words.) 76 Drug Candidate 75 Reduces Risk 74 Increases Risk 74 Drug Resistant 74 Meta Analysis 74 Prostate Cancer Patients 73 Holds Promise 73 Shows Promise 73 Clinical Trial Results 73 Early Diagnosis 73 Inhibits 73 Elderly Patients 73 Blood Clots 73 Heart Failure Patients 73 Helps Prevent 73 Postmenopausal Women 73 Gastric Cancer 72 Treatable 72 Bladder Cancer 72 Scientists Identify 72 Prostate Cancer Treatment 72 Cancer Treatments 72 Breast Cancer Treatment 71 Study Demonstrates 71 Preclinical Data 71 Atopic Dermatitis 71 Ear Infections 71 Blood Vessels 71 Gum Disease 71 Venous Thromboembolism 71 FDA Clears 71 Autoimmune Diseases 71 Brain Tumors 71 Increased Risk 71 Completes Enrollment 71 Brain Cells 71 Overactive Bladder 70 Breast Cancer Patients 70 Benign Prostatic Hyperplasia 70 Chronic Heart Failure 70 Researchers Identify 70 Induces 70 Insulin Resistance 70 RNAi Therapeutics 70 Systematic Review 70 Targeted Therapy 70 Low Dose 70 Study Identifies 70 Advanced Prostate Cancer 70 Presents Positive 70 Int J 70 Blood Thinner 70 Study Indicates 69 Esophageal Cancer 69 Reduce Risk 69 Significantly Reduces 69 Phase III Trial 69 Hormone Therapy 69 Patients Treated 69 Cancer Cells 69 Malaria Vaccine 69 Smallpox Vaccine 68 Thyroid Cancer 68 Monoclonal Antibodies 68 Cholesterol Drug 68 Cancer Diagnosis 68 Protects Against 68 #:#-# [023] 68 Chronic Hepatitis C 68 Pipeline Analysis 68 Study Examines 68 Insights Into 68 Small Molecule 68 Patient Enrollment 68 Cancer Vaccines 68 Chronic Lymphocytic Leukemia 68 Stem Cell Transplant 67 Allergic Rhinitis 67 Diabetic Patients 67 Dialysis Patients 67 Drug Pipeline 67 FDA Accepts 67 Prostate Cancer Risk 67 Well Tolerated 67 Cervical Cancer Vaccine 67 Healthbeat 67 Study Suggests 67 Pancreatic 67 #:#-# [037] 67 Ischemic 67 Free Full Text 67 Non Invasive 67 Study Links 67 Genetic Testing 67 Study Confirms 67 Cardiovascular Events 67 Metastatic Colorectal Cancer 67 Urinary Incontinence 66 Pulmonary Arterial Hypertension 66 Cancer Therapies 66 Phase III Clinical Trial